Javascript must be enabled to continue!
Achromobacter pneumonia in a patient with advanced COPD, a diagnostic challenge
View through CrossRef
Bacterial pneumonia causes significant morbidity and mortality especially in elderly and immunocompromised hosts. Achromobacter xylosoxidans denitrificans pneumonia is very rarely reported. However, the reported cases have been in patients who are either immunocompromised or have bronchiectasis. We hereby present a unique case of Achromobacter xylosoxidans denitrificans pneumonia in an immunocompetent patient with advanced chronic obstructive pulmonary disease (COPD). Our patient is a Caucasian male admitted with shortness of breath, fever and cough. Chest X-ray demonstrated right-sided infiltrates and he was treated with intravenous ceftriaxone and azithromycin. He was discharged home on oral amoxicillin-clavulanate 875–125 mg two times per day for a total of 7 days. Patient returned to emergency room after 5 weeks with persistent symptoms and chest X-ray revealed persistent right-sided infiltrate and sputum culture showed Achromobacter xylosoxidans denitrificans. The patient was started on oral levofloxacin 750 mg one time per day for 2 weeks with resolution of symptoms.
Title: Achromobacter pneumonia in a patient with advanced COPD, a diagnostic challenge
Description:
Bacterial pneumonia causes significant morbidity and mortality especially in elderly and immunocompromised hosts.
Achromobacter xylosoxidans denitrificans pneumonia is very rarely reported.
However, the reported cases have been in patients who are either immunocompromised or have bronchiectasis.
We hereby present a unique case of Achromobacter xylosoxidans denitrificans pneumonia in an immunocompetent patient with advanced chronic obstructive pulmonary disease (COPD).
Our patient is a Caucasian male admitted with shortness of breath, fever and cough.
Chest X-ray demonstrated right-sided infiltrates and he was treated with intravenous ceftriaxone and azithromycin.
He was discharged home on oral amoxicillin-clavulanate 875–125 mg two times per day for a total of 7 days.
Patient returned to emergency room after 5 weeks with persistent symptoms and chest X-ray revealed persistent right-sided infiltrate and sputum culture showed Achromobacter xylosoxidans denitrificans.
The patient was started on oral levofloxacin 750 mg one time per day for 2 weeks with resolution of symptoms.
Related Results
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Suffering of Patients with Neurogenic Thoracic Outlet Syndrome (TOS); The First Qualitative study in TOS
Suffering of Patients with Neurogenic Thoracic Outlet Syndrome (TOS); The First Qualitative study in TOS
Abstract
Background
Diagnosis of neurogenic thoracic outlet syndrome (nTOS) is hindered by symptom overlap with cervical radiculopathy, carpal tunnel syndrome, or psychosomatic dis...
Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population
Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population
Abstract
Objective
Chronic obstructive pulmonary disease (COPD) is a complex, multifactorial, polygenic disease. The rate of occurrence of COPD in t...
1711. In Vitro Activity of Cefiderocol Against US Achromobacter spp. and Burkholderia spp. Clinical Isolates from the SENTRY Surveillance Program 2020-2021
1711. In Vitro Activity of Cefiderocol Against US Achromobacter spp. and Burkholderia spp. Clinical Isolates from the SENTRY Surveillance Program 2020-2021
Abstract
Background
Infections caused by Achromobacter spp. and Burkholderia spp. have limited clinical treatment options due to...
Phenotypic Differences between Patients with Smoking Chronic Obstructive Pulmonary Disease and Non-smoking Chronic Obstructive Pulmonary Disease
Phenotypic Differences between Patients with Smoking Chronic Obstructive Pulmonary Disease and Non-smoking Chronic Obstructive Pulmonary Disease
Background:
In low- and middle-income countries, causes other than tobacco smoking contribute more to the development of chronic obstructive pulmonary disease (COPD). I...

